Pacientes
Socios

Biblioteca

Alertas Bibliográficas

DIABETES

Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani M, Maffei P, DeFronzo RA.
Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X. 
doi: 10.1016/S2213-8587(24)00127-X

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 
Phillip M, Achenbach P, Addala A et al.
Diabetes. Diabetes Care. 2024.
doi:10.2337/dci24-004

Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Richard I G Holt, Clive S Cockram, Ronald C W Ma , Andrea O Y Luk
Diabetologia. 2024 Jul;67(7):1168-1180.
doi: 10.1007/s00125-024-06102-x

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R Tuttle, Peter Rossing, et al,N Engl J Med. 2024 May 24. 
doi: 10.1056/NEJMoa2403347

Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen I Stone, Ashok Balasubramanyam, Jennifer E Posey 
Diabetes Care. 2024 May 1;47(5):770-781. 
doi.org/10.2337/dci23-0038

ENDOCRINOLOGÍA​

Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol. 
Lanzolla G, Marinò M, Menconi F. 
Published online July 22, 2024. 
doi:10.1038/s41574-024-01016-5

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed MediatorsMulders MCF, de Herder WW, Hofland J.Endocr Rev. 2024 May 7;45(3):351-360. 
doi: 10.1210/endrev/bnad035

Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.Mullen N, Curneen J, Donlon PT, et al.
Endocr Rev. 2024 Jan 4;45(1):125-170. 
doi: 10.1210/endrev/bnad026

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia
Kyriakie Sarafoglou, Mimi S Kim, Maya Lodish, et al.
N Engl J Med. 2024 Jun 2. 
doi: 10.1056/NEJMoa2404655

PEDIATRÍA

Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al.
N Engl J Med. 2019 Aug 15;381(7):637-646.
http://doi.org/10.1056/NEJMoa1903822

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D, Aversa T, Ruggeri RM, Cristani M, Alibrandi A, et al.
Front Endocrinol (Lausanne). 2019 Jun 28;10:426.
http://doi.org/10.3389/fendo.2019.00426

Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report.
Goedegebuure WJ, Hokken-Koelega ACS.
Horm Res Paediatr. 2019 Aug 7:1-5.
http://doi.org/10.1159/000501746

Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome.
Singh P, Mahmoud R, Gold JA, Miller JL, Roof E, Tamura R, et al.
J Med Genet. 2018 May 18. pii: jmedgenet-2017-105118.
http://doi.org/10.1136/jmedgenet-2017-105118

Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life.
Çizmecioğlu FM, Jones JH, Paterson WF, Kherra S, Kourime M, McGowan R, et al.
J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):264-273.
http://doi.org/10.4274/jcrpe.0029

CIENCIAS BÁSICAS

Effect of Iodothyronines on Thermogenesis: Focus on Brown Adipose Tissue.
Cioffi F, Gentile A, Silvestri E, Goglia F, Lombardi A.
Front Endocrinol (Lausanne). 2018 May 23;9:254.
http://doi.org/10.3389/fendo.2018.00254
eCollection 2018. Review. PubMed PMID: 29875734; PubMed Central PMCID: PMC5974034.

MicroRNA-204-5p regulates 3T3-L1 preadipocyte proliferation, apoptosis and differentiation.
Du J, Zhang P, Gan M, Zhao X, Xu Y, Li Q et al.
Gene. 2018 Aug 20;668:1-7.
http://doi.org/10.1016/j.gene.2018.05.036 
Epub 2018 May 18. PubMed PMID: 29775748.

The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects.
Froy O, Garaulet M.
Endocr Rev. 2018 Jun1;39(3):261-273.
http://doi.org/10.1210/er.2017-00193
PubMed PMID: 29490014